Difference between revisions of "Gallbladder adenoma"

Jump to navigation Jump to search
302 bytes added ,  20:48, 1 October 2021
Line 22: Line 22:
Notes:
Notes:
*Low grade dysplasia should prompt targeted sampling and review.<ref name=uscap2017_akki/>
*Low grade dysplasia should prompt targeted sampling and review.<ref name=uscap2017_akki/>
*Gallbladders with high grade dysplasia should be [[submitted in total]] to exclude [[gallbladder adenocarcinoma]].<ref name=uscap2017_akki>Akki ''et al.'' (2017) "Detecting Incidental Gallbladder Adenocarcinoma: When to Submit the Entire Gallbladder".  Available at: [http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016 http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016]. United States and Canadian Academy of Pathology Annual Meeting. Accessed on: April 9, 2017.</ref>
*Gallbladders with high grade dysplasia should be [[submitted in total]] to exclude [[gallbladder adenocarcinoma]].<ref name=uscap2017_akki>Akki ''et al.'' (2017) "Detecting Incidental Gallbladder Adenocarcinoma: When to Submit the Entire Gallbladder".  Available at: [http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016 http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016]. United States and Canadian Academy of Pathology Annual Meeting. Accessed on: April 9, 2017.</ref><ref name=pmid33629395/>
 
Grading:<ref name=pmid33629395>{{cite journal |vauthors=Roa JC, Basturk O, Adsay V |title=Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications |journal=Histopathology |volume=79 |issue=1 |pages=2–19 |date=July 2021 |pmid=33629395 |doi=10.1111/his.14360 |url=}}</ref>
*Low-grade.
*High-grade.


DDx:
DDx:
*[[Gallbladder adenocarcinoma]].
*[[Gallbladder adenocarcinoma]].
*Reactive changes.
*Reactive changes.
===Grading dysplasia===
Low grade dysplasia:<ref name=pmid33629395>{{cite journal |vauthors=Roa JC, Basturk O, Adsay V |title=Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications |journal=Histopathology |volume=79 |issue=1 |pages=2–19 |date=July 2021 |pmid=33629395 |doi=10.1111/his.14360 |url=}}</ref>
*Surface epithelium changes: gyperchromasia, pseudostratification, elongated nuclei; nuclei stratfied/confined mainly to lower aspect of the epithelium.
High grade dysplasia:<ref name=pmid33629395/>
**Diffuse and severe (cytologic) atypia: nuclei no long stratified.


===Images===
===Images===
48,851

edits

Navigation menu